vs
Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $41.3M, roughly 1.4× Northfield Bancorp, Inc.). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -83.0% vs -1545.5%, a 1462.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 12.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 15.0%).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
NFBK vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.3M | $57.3M |
| Net Profit | $-27.4M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -1263.3% | -82.2% |
| Net Margin | -1545.5% | -83.0% |
| Revenue YoY | 12.7% | 36.9% |
| Net Profit YoY | -343.6% | -9.6% |
| EPS (diluted) | $-0.68 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.3M | $57.3M | ||
| Q3 25 | $39.2M | $51.3M | ||
| Q2 25 | $38.9M | $48.5M | ||
| Q1 25 | $34.8M | $32.7M | ||
| Q4 24 | $36.7M | $41.8M | ||
| Q3 24 | $31.8M | $33.3M | ||
| Q2 24 | $31.5M | $29.1M | ||
| Q1 24 | $31.3M | $26.0M |
| Q4 25 | $-27.4M | $-47.5M | ||
| Q3 25 | $10.8M | $-52.9M | ||
| Q2 25 | $9.6M | $-46.6M | ||
| Q1 25 | $7.9M | $-49.5M | ||
| Q4 24 | $11.3M | $-43.3M | ||
| Q3 24 | $6.5M | $-43.6M | ||
| Q2 24 | $6.0M | $-32.3M | ||
| Q1 24 | $6.2M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -1263.3% | -82.2% | ||
| Q3 25 | 37.7% | -102.6% | ||
| Q2 25 | 35.6% | -93.4% | ||
| Q1 25 | 31.0% | -143.7% | ||
| Q4 24 | 38.0% | -98.6% | ||
| Q3 24 | 27.9% | -132.0% | ||
| Q2 24 | 29.1% | -139.2% | ||
| Q1 24 | 27.2% | -538.7% |
| Q4 25 | -1545.5% | -83.0% | ||
| Q3 25 | 27.4% | -103.1% | ||
| Q2 25 | 24.6% | -96.1% | ||
| Q1 25 | 22.6% | -151.4% | ||
| Q4 24 | 30.7% | -103.6% | ||
| Q3 24 | 20.5% | -131.2% | ||
| Q2 24 | 18.9% | -110.9% | ||
| Q1 24 | 19.9% | -544.4% |
| Q4 25 | $-0.68 | $-0.73 | ||
| Q3 25 | $0.27 | $-0.82 | ||
| Q2 25 | $0.24 | $-0.75 | ||
| Q1 25 | $0.19 | $-0.81 | ||
| Q4 24 | $0.27 | $-0.71 | ||
| Q3 24 | $0.16 | $-0.73 | ||
| Q2 24 | $0.14 | $-0.55 | ||
| Q1 24 | $0.15 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.0M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $690.1M | $139.1M |
| Total Assets | $5.8B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.0M | $388.9M | ||
| Q3 25 | $131.7M | $416.1M | ||
| Q2 25 | $97.6M | $291.0M | ||
| Q1 25 | $101.7M | $314.5M | ||
| Q4 24 | $167.7M | $320.6M | ||
| Q3 24 | $232.9M | $298.4M | ||
| Q2 24 | $153.5M | $319.1M | ||
| Q1 24 | $238.8M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $666.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $690.1M | $139.1M | ||
| Q3 25 | $719.6M | $148.8M | ||
| Q2 25 | $710.3M | $-11.9M | ||
| Q1 25 | $711.1M | $18.9M | ||
| Q4 24 | $704.7M | $21.7M | ||
| Q3 24 | $699.6M | $11.2M | ||
| Q2 24 | $693.0M | $39.3M | ||
| Q1 24 | $698.4M | $61.6M |
| Q4 25 | $5.8B | $480.2M | ||
| Q3 25 | $5.7B | $506.9M | ||
| Q2 25 | $5.7B | $372.7M | ||
| Q1 25 | $5.7B | $386.7M | ||
| Q4 24 | $5.7B | $392.3M | ||
| Q3 24 | $5.7B | $363.6M | ||
| Q2 24 | $5.7B | $381.8M | ||
| Q1 24 | $5.9B | $258.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.95× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.7M | $-25.4M |
| Free Cash FlowOCF − Capex | $52.5M | — |
| FCF MarginFCF / Revenue | 127.1% | — |
| Capex IntensityCapex / Revenue | 2.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $89.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.7M | $-25.4M | ||
| Q3 25 | $13.9M | $-26.6M | ||
| Q2 25 | $14.1M | $-23.3M | ||
| Q1 25 | $9.4M | $-40.4M | ||
| Q4 24 | $31.1M | $-18.8M | ||
| Q3 24 | $14.0M | $-25.2M | ||
| Q2 24 | $6.9M | $-29.1M | ||
| Q1 24 | $4.2M | $-40.7M |
| Q4 25 | $52.5M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $13.9M | — | ||
| Q1 25 | $9.2M | — | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $13.7M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 127.1% | — | ||
| Q3 25 | 34.6% | — | ||
| Q2 25 | 35.7% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | 81.6% | — | ||
| Q3 24 | 43.2% | — | ||
| Q2 24 | 21.1% | — | ||
| Q1 24 | 12.1% | — |
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
